Skip to content
Clinical Trials – home

Slaskie Centrum Chorob Serca W Zabrzu

Research site

Poland Ul. Marii Curie-Sklodowskiej 9, 41-800 Zabrze, Poland

  • 14 trials recruiting
  • Atrial fibrillation · Cardiac failure · Acute myocardial infarction
  • Adults and children

About Specializations

Slaskie Centrum Chorob Serca W Zabrzu in Zabrze, Poland specialises in clinical trials of conditions such as Atrial fibrillation, Cardiac failure, Acute myocardial infarction, Arteriosclerosis, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Medicine

The medical center is at the forefront of cardiovascular medicine, focusing on innovative treatments for acute myocardial infarction and related conditions. The center's research aims to improve outcomes for patients through advanced therapeutic strategies.

  • Acute Myocardial Infarction
  • Heart Failure
  • Cardiomyopathy

By integrating cutting-edge research with clinical practice, the center is enhancing the management of cardiovascular diseases, offering patients access to the latest advancements in treatment.

Transplant Medicine

Specializing in lung transplant rejection, the center is dedicated to improving the longevity and quality of life for transplant recipients. Research efforts are focused on optimizing immunosuppressive therapies and monitoring techniques.

  • Lung Transplant Rejection
  • Immunosuppressive Therapy
  • Post-Transplant Care

The center's commitment to transplant medicine is evident in its comprehensive approach to patient care, ensuring that each patient receives personalized and effective treatment.

Cardiac Imaging and Structural Heart Disease

With a focus on obstructive hypertrophic cardiomyopathy, the center is pioneering the use of advanced imaging techniques to assess and treat structural heart diseases. This research is crucial for developing targeted therapies that improve patient outcomes.

  • Obstructive Hypertrophic Cardiomyopathy
  • Cardiac Magnetic Resonance Imaging
  • Structural Heart Disease

The center's expertise in cardiac imaging is transforming the diagnosis and management of complex heart conditions, providing patients with state-of-the-art care.

Heart Failure and Cardiotoxicity Prevention

Research at the center is advancing the understanding of heart failure and its prevention, particularly in patients undergoing cancer treatment. The focus is on mitigating cardiotoxic effects and improving cardiac function.

  • Heart Failure Prevention
  • Cardiotoxicity in Cancer Treatment
  • Cardiac Function Improvement

Through innovative research, the center is leading efforts to protect heart health in vulnerable populations, ensuring better long-term outcomes for patients.

Arrhythmia and Electrophysiology

The center is a leader in the study of arrhythmogenic cardiomyopathy, focusing on the development of therapies that address the underlying causes of arrhythmias. This research is vital for improving the quality of life for patients with complex cardiac conditions.

  • Arrhythmogenic Cardiomyopathy
  • Electrophysiological Interventions
  • Anti-Arrhythmic Therapies

By advancing the field of electrophysiology, the center is providing patients with innovative solutions to manage and treat arrhythmias effectively.

Renal and Cardiovascular Interactions

Focusing on the intersection of atrial fibrillation and renal disease, the center is exploring novel antiplatelet strategies to reduce stroke risk and bleeding events. This research is crucial for patients with complex comorbidities.

  • Atrial Fibrillation Management
  • Renal Disease and Cardiovascular Health
  • Antiplatelet Therapy Optimization

The center's research is paving the way for integrated care approaches that address the unique challenges faced by patients with both renal and cardiovascular conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Marii Curie-Sklodowskiej 941-800 ZabrzePoland
Recruiting now
14 trials
Conditions studied
18

More sites in ZabrzePoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

25 clinical trials

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Study on the Effects of Ferric Carboxymaltose on Heart Health and Quality of Life in Patients with Recent Heart Attack and Iron Deficiency

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Agencja Badań Medycznych

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational
Countries:PolandPoland
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Iron deficiency

Recruiting

Effect of Ferric Carboxymaltose, Ferrous Sulfate, and Sodium Chloride vs Placebo on Physical Performance in Frail Elderly with Iron Deficiency and Cardiovascular Disease

Registered drug
Countries:PolandPoland
  • Participants:65+ years
  • Substances:Sodium Chloride
  • Sponsor:Wroclaw Medical University

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:POLYPEPTIDE CONSISTING OF A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND AN AMYLIN RECEPTOR AGONIST, CONNECTED BY A LINKER WITH 4 GLYCINE RESIDUES, AND CONNECTED TO A C18 FATTY ACID SIDE CHAIN
  • Sponsor:Novo Nordisk A/S

Study comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Agencja Badań Medycznych

Study of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:AP31969 sulfate
  • Sponsor:Acesion Pharma ApS

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Pharmacosmos A/S

Cardiac failure+1

Recruiting

Study on the Effects of CDR132L on Heart Structure and Function in Patients with Heart Failure and Left Ventricular Hypertrophy

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

Study on the Effects of Sacubitril/Valsartan and Ramipril on Heart Function in Patients with Ischemic Heart Failure with Mid-Range Ejection Fraction

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Hydrochlorothiazide
  • Sponsor:Krakowski Szpital Specjalistyczny Im. Sw. Jana Pawla II

Cardiac failure

Recruiting

Study on Sacubitril and Valsartan to Prevent Heart Damage in Breast Cancer Patients Undergoing Treatment

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sacubitril
  • Sponsor:Agencja Badań Medycznych
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.